Oramed Pharmaceuticals Price to Sales Ratio 2012-2025 | ORMP
Historical PS ratio values for Oramed Pharmaceuticals (ORMP) over the last 10 years. The current P/S ratio for Oramed Pharmaceuticals as of April 10, 2026 is .
| Oramed Pharmaceuticals P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-04-10 | 3.53 | 72.77 | |
| 2025-12-31 | 2.66 | $0.05 | 54.77 |
| 2025-09-30 | 2.46 | $0.05 | 50.73 |
| 2025-06-30 | 2.10 | $0.05 | 43.24 |
| 2025-03-31 | 2.00 | $0.05 | 41.13 |
| 2024-12-31 | 2.26 | 0 | 0.00 |
| 2024-09-30 | 2.27 | 0 | 0.00 |
| 2024-06-30 | 2.40 | 0 | 0.00 |
| 2024-03-31 | 2.72 | $0.02 | 162.47 |
| 2023-12-31 | 2.15 | $0.03 | 64.50 |
| 2023-09-30 | 2.43 | $0.05 | 47.85 |
| 2023-06-30 | 3.34 | $0.07 | 48.87 |
| 2023-03-31 | 2.03 | $0.07 | 29.49 |
| 2022-12-31 | 11.22 | $0.07 | 161.38 |
| 2022-09-30 | 6.04 | $0.02 | 277.77 |
| 2022-06-30 | 4.27 | $0.02 | 188.22 |
| 2022-03-31 | 8.06 | $0.03 | 321.83 |
| 2021-12-31 | 13.31 | $0.01 | 0.00 |
| 2021-11-30 | 17.92 | $0.06 | 298.30 |
| 2021-09-30 | 20.49 | $0.06 | 317.98 |
| 2021-08-31 | 18.35 | $0.07 | 267.79 |
| 2021-06-30 | 12.47 | $0.09 | 133.92 |
| 2021-05-31 | 10.74 | $0.10 | 107.86 |
| 2021-03-31 | 9.47 | $0.08 | 123.30 |
| 2021-02-28 | 8.31 | $0.08 | 100.89 |
| 2020-11-30 | 3.97 | $0.10 | 41.57 |
| 2020-08-31 | 3.25 | $0.11 | 30.77 |
| 2020-05-31 | 2.93 | $0.11 | 27.68 |
| 2020-02-29 | 3.80 | $0.12 | 32.94 |
| 2019-11-30 | 4.11 | $0.12 | 35.50 |
| 2019-08-31 | 3.10 | $0.12 | 26.72 |
| 2019-05-31 | 2.80 | $0.12 | 24.14 |
| 2019-02-28 | 2.98 | $0.12 | 25.01 |
| 2018-11-30 | 3.80 | $0.12 | 30.94 |
| 2018-08-31 | 4.61 | $0.13 | 36.27 |
| 2018-05-31 | 7.37 | $0.13 | 57.96 |
| 2018-02-28 | 6.76 | $0.13 | 51.55 |
| 2017-11-30 | 8.52 | $0.14 | 62.97 |
| 2017-08-31 | 8.06 | $0.14 | 58.19 |
| 2017-05-31 | 7.60 | $0.14 | 54.82 |
| 2017-02-28 | 5.64 | $0.10 | 53.91 |
| 2016-11-30 | 5.72 | $0.07 | 83.57 |
| 2016-08-31 | 6.72 | $0.02 | 301.36 |
| 2016-05-31 | 8.13 | $0.02 | 364.48 |
| 2016-02-29 | 6.61 | $0.01 | 0.00 |
| 2015-11-30 | 8.48 | 0 | 0.00 |
| 2015-08-31 | 5.24 | 0 | 0.00 |
| 2015-05-31 | 6.21 | 0 | 0.00 |
| 2015-02-28 | 4.21 | 0 | 0.00 |
| 2014-11-30 | 5.59 | 0 | 0.00 |
| 2014-08-31 | 9.45 | 0 | 0.00 |
| 2014-05-31 | 7.77 | 0 | 0.00 |
| 2014-02-28 | 13.85 | 0 | 0.00 |
| 2013-11-30 | 7.74 | 0 | 0.00 |
| 2013-08-31 | 6.80 | 0 | 0.00 |
| 2013-05-31 | 8.56 | 0 | 0.00 |
| 2013-02-28 | 8.39 | 0 | 0.00 |
| 2012-12-31 | 3.69 | 0 | 0.00 |
| 2012-11-30 | 3.47 | 0 | 0.00 |
| 2012-08-31 | 3.56 | 0 | 0.00 |
| 2012-05-31 | 3.78 | 0 | 0.00 |
| 2012-02-29 | 3.15 | 0 | 0.00 |
| 2011-11-30 | 3.36 | 0 | 0.00 |
| 2011-09-30 | 3.90 | 0 | 0.00 |
| 2011-08-31 | 3.24 | 0 | 0.00 |
| 2011-06-30 | 3.27 | 0 | 0.00 |
| 2011-05-31 | 3.69 | 0 | 0.00 |
| 2011-03-31 | 3.02 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.143B | $0.002B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Stryker (SYK) | United States | $129.889B | 24.88 |
| Medtronic (MDT) | Ireland | $111.968B | 15.57 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Koninklijke Philips (PHG) | Netherlands | $27.260B | 16.18 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Insulet (PODD) | United States | $13.640B | 39.54 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Prestige Consumer Healthcare (PBH) | United States | $2.676B | 12.62 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.495B | 3.96 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.953B | 164.50 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |